Author

Li-Feng Li

h-index 5 View on Semantic Scholar

We have 2 of 17 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Neural-Metabolic Crosstalk Governing Cell Death and Therapy Resistance in Tumors.

Metabolic reprogramming and resistance to regulated cell death (RCD) are central features of the tumor microenvironment (TME) that drive therapeutic failure. Emerging evidence indicates that neurotransmitter signaling networks-including glutamate, dopamine, 5-hydroxytryptamine (5-HT), and norepinephrine-extend beyond n...

Yi-Ming Yan, Hao-Jie Sun, Zi-Qiang Liu et al. · Pharmacological Research · 0 citations

Review Open access Jul 2026

Delivery Systems for Therapeutic Genome Editing: Challenges, Innovations, and Future Perspectives

This review provides a comprehensive overview of current and emerging delivery systems for genome editing, highlighting key innovations, unresolved challenges, and interdisciplinary strategies poised to unlock broader therapeutic potential.

Meijia Yang, Yiqiong Song, Ziyang Wang et al. · MedComm · 0 citations